Norisato Mitsutake
Papers
1
Total Citations
26
H-Index
1
About
Norisato Mitsutake is a leading thyroid cancer researcher whose work has fundamentally advanced our understanding of the molecular mechanisms driving papillary thyroid carcinoma (PTC). His research focuses on the role of RET/PTC rearrangements—key tumor-initiating events in PTC—and their downstream signaling pathways. In his highly cited 2003 study (26 citations), Mitsutake made a seminal contribution by identifying microsomal prostaglandin E2 synthase-1 (mPGES-1) as a RET/PTC-inducible gene. Using subtraction hybridization cloning and custom microarrays in thyroid PCCL3 cells, he demonstrated that mPGES-1 expression is driven through the MEK-ERK pathway, revealing a novel link between oncogenic rearrangements and prostaglandin signaling in thyroid carcinogenesis. This work provided critical insights into how RET/PTC transforms thyroid cells and opened new avenues for understanding inflammation-associated cancer progression. Mitsutake's research continues to shape the field, offering potential targets for therapeutic intervention in aggressive thyroid cancers.
Research Focus
Key Achievements
Top Papers
- 1